Clinical Trial Update: Eltrombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study evaluating eltrombopag for chemotherapy-induced thrombocytopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Chemotherapy-induced Thrombocytopenia, Eltrombopag | Phase 2 | Status: RECRUITING